Search for: "C Lillie"
Results 181 - 200
of 447
Sort by Relevance
|
Sort by Date
22 Jul 2015, 12:40 pm
Lilly lists a single count in this lawsuit - infringement of U.S. [read post]
20 Jul 2015, 2:43 am
| Plant variety in Case C‑242/14 | US Supreme Court on Spiderman patent | Hospira v Genentech saga | Are EU policy-makers fighting the right copyright battles? [read post]
16 Jul 2015, 4:00 am
This addresses a problem seen, for example, in the decision in Lilly Icos LLC v. [read post]
13 Jul 2015, 3:51 am
| Plant variety in Case C‑242/14 | US Supreme Court on spiderman patent | Hospira v Genentech saga | Are EU policy-makers fighting the right copyright battles? [read post]
12 Jul 2015, 6:41 am
Inconforme COSVI, acudió al Tribunal Supremo y sostuvo que lo resuelto en Lilly del Caribe, Inc. v. [read post]
7 Jul 2015, 1:55 pm
Indianapolis, Indiana - In conjunction with non-Indiana co-counsel, an Indiana patent attorney for Eli Lilly and Company, Eli Lilly Export S.A. [read post]
6 Jul 2015, 12:36 pm
* Benna, Bnina, Baina: a carefully-scripted ruling from the CJEU Case C 147/14 Loutfi Management Propriété intellectuelle SARL v AMJ Meatproducts NV, Halalsupply NV is a Court of Justice of the European Union (CJEU) ruling regarding trade marks containing both Arabic and Latin letters. [read post]
2 Jul 2015, 4:00 am
Some additional amendments to the Copyright Act relating to access to works for people with disabilities were introduced in Bill C-65 in June. [read post]
28 Jun 2015, 5:34 am
Claim 1 of the patent in suit (as amended in earlier proceedings) reads:A method of preparing a light stabilized antimicrobial material, characterised in that the method comprises the steps of:(a) preparing a solution comprising anorganic solvent and a source of silver in a quantity sufficient to provide a desired silver concentration in said material;(b) subjecting a material which includes gel-forming fibres containing one or more hydrophilic, amphoteric or anionic polymers to said solution for a… [read post]
26 Jun 2015, 4:10 am
Writes Nick:The CJEU proceedings in Case C-34/10 concerned the German national patent. [read post]
9 Jun 2015, 1:06 pm
For example, after reviewing several studies, Professor Peter C. [read post]
26 May 2015, 2:50 pm
Under Rules 2-01(b) and (c) of Regulation S-X, an auditor is considered not to be “independent” if, at any time during the engagement, the auditor provides prohibited non-auditor services to the client, such as bookkeeping or financial statement preparation services. [read post]
26 May 2015, 2:50 pm
Under Rules 2-01(b) and (c) of Regulation S-X, an auditor is considered not to be “independent” if, at any time during the engagement, the auditor provides prohibited non-auditor services to the client, such as bookkeeping or financial statement preparation services. [read post]
26 May 2015, 12:53 pm
This patent covers a method of using Effient products for which Lilly claims an exclusively license. [read post]
26 May 2015, 7:42 am
The ideal defendant’s case might occur in several ways: similar biomarker evidence would point a finger at a purely genetic cause or at some other (perhaps voluntary or non-anthropogenic) exposure; or, a person exposed to a toxin known to cause the person's disease in susceptible people might have a gene that completely neutralized the toxic effect and also might lack a biomarker that is uniformly found in people whose disease was caused by exposure.Steve C. [read post]
22 May 2015, 7:18 am
C-14-5006, 2015 U.S. [read post]
13 May 2015, 4:00 am
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
29 Apr 2015, 11:15 am
(collectively "Lupin"), to Lilly's Indiana patent litigation efforts. [read post]
9 Apr 2015, 5:00 am
Eli Lilly & Co., 503 F. [read post]
10 Mar 2015, 11:55 pm
Evid. 801(c)(2)3. [read post]